#EXAS↓

Featured/ EXAS/ 11/20/2025 · 7:46 AM

Abbott Makes Major Move in Cancer Diagnostics with $21B Exact Sciences Acquisition

Abbott to acquire Exact Sciences for $21 billion, gaining leadership in cancer screening with Cologuard and expanding its diagnostics portfolio into fast-growing oncology segment.

Featured/ EXAS/ 11/19/2025 · 2:28 PM

Abbott Laboratories Eyes Largest Deal in Decade with Exact Sciences Acquisition

Abbott Laboratories is in talks to acquire Exact Sciences Corp. for ~$16B, marking its biggest healthcare deal of 2025 and largest acquisition in nearly 10 years.